Butterfly Network (BFLY) Share-based Compensation Growth (1y) (2021 - 2026)
Butterfly Network (BFLY) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -30.44% |
| 10 | Butterfly Network | 1.76 Bn | 1.62 Bn | 18.29 Mn | 99.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.71% |
| Dec 31, 2025 | -1.77% |
| Sep 30, 2025 | 9.36% |
| Jun 30, 2025 | 0.09% |
| Mar 31, 2025 | -49.76% |
| Dec 31, 2024 | 200.52% |
| Sep 30, 2024 | -35.26% |
| Jun 30, 2024 | -40.96% |
| Mar 31, 2024 | 32.00% |
| Dec 31, 2023 | -238.54% |
| Sep 30, 2023 | -27.60% |
| Jun 30, 2023 | 6.88% |
| Mar 31, 2023 | -52.06% |
| Dec 31, 2022 | 139.36% |
| Sep 30, 2022 | -12.31% |
| Jun 30, 2022 | 19.99% |
| Mar 31, 2022 | -56.99% |
| Dec 31, 2021 | -1,270.86% |
| Sep 30, 2021 | 351.20% |
| Jun 30, 2021 | 190.68% |